SRPT   $114.27  3.41% Market Closed After Close 114.5 0.20%

Sarepta Therapeutics Inc
Total Cash 1.46B
totalCashPerShare 15.314
EBITDA 77.75M
Total Debt 1.39B
quickRatio 2.691
currentRatio 3.898
Total Revenue 1.50B
debtToEquity 128.779
Revenue/Share 15.789
ROA 0.0072500003
ROE 0.052020002
grossProfits
freeCashflow -408.09M
operatingCashflow -396.50M
earningsGrowth
revenueGrowth 0.389
grossMargins 0.37129003
ebitdaMargins 0.051659998
operatingMargins -0.00193
profitMargins 0.03143
enterpriseValue 11.85B
forwardPE 11.3748865
floatShares 91.00M
sharesOutstanding 95.37M
sharesShort 5.66M
sharesShortPriorMonth 6.15M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.94%
Short Ratio help_outline 7.23%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 11.304
Price To Book help_outline 11.06
earningsQuarterlyGrowth
netIncomeToCommon 47.30M
trailingEps 0.75%
forwardEps 10.99%
enterpriseToEbitda 152.39
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.13 3Q 2024
institutionsCount 665
lastUpdated Nov. 6, 2024, 5:27 p.m.